Retina – Anders Kvanta's research group

The research team is led by Professor Anders Kvanta, with an aim to provide new insights into degenerative retinal diseases, with high focus on translational therapy strategies for patients with blinding diseases.

Part of the:

Anders Kvanta's research group conducts translational studies on common retinal diseases such as age-related macular degeneration and inherited retinal degeneration (retinitis pigmentosa). The research involves natural history studies, new imaging techniques, optimization of existing treatments, as well as the development of gene therapy and stem cell-based therapies.

 

News

Promobilia supports KI research on treatments for age-related visual impairment
portrait Photo: Stefan Zimermann och Ulf Sirborn

Promobilia supports KI research on treatments for age-related visual impairment

Fellow-KI researchers Anders Kvanta and Fredrik Lanner have been awarded a grant of SEK 10 million from the Promobilia foundation to develop a treatment for inherited retinal diseases, such as retinitis pigmentosa (RP), and age-related macular degeneration (AMD). There is currently no effective therapies for these diseases, which are the main cause of blindness in the developed world.

Publications

All publications from group members

Funding

Standing funding

·Novo Nordisk Collaborative support

·The ARMEC Lindberg Foundation

·ALF Medicine

·The Swedish Eye Foundation

·The Crown Princess Margareta Association for the Visually Impaired

·The Edwin Jordan Foundation

·KI Foundations and Funds

Staff and contact

Group leader

All members of the group

Group Alumni

Selçuk Tunik, Associate Professor at University of Dicle, Turkey

Effat Alizadeh, Associate Professor at Tabriz University of Medical Sciences, Iran

Jóhann Gu∂mundsson, Head of Ophthalmology at Lanspitali, Iceland

Sandra Petrus-Reurer, Postdoc at Cambridge University, UK

Parviz Mammadzada, MD Ophthalmology Specialist at Örebro hospital, Sweden

Research projects

 

  • Natural history studies in age-related macular degeneration and inherited retinal degeneration.

     

  • Advanced imaging techniques in age-related macular degeneration and inherited retinal degeneration.

     

  •  Optimization of current treatments for the wet form of age-related macular degeneration.

     

  •  Gene therapy for RLBP1-associated retinitis pigmentosa (Bothnia dystrophy).

     

  • Development of stem cell-based therapy for the dry form of age-related macular degeneration (geographic atrophy) and inherited retinal degeneration.

     

 

Support our research

Support our research

Support our research

In balance with St. Erik Eye Hospital, the Kvanta/André lab thrives to be able to treat and cure all existing eye diseases. Help by investing in better vision in the future.